Metropolitan Life Insurance Company (MetLife)’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,051
| Closed | -$23K | – | 918 |
|
|
2024
Q1 | $23K | Hold |
3,051
| – | – | ﹤0.01% | 1789 |
|
|
2023
Q4 | $28.3K | Hold |
3,051
| – | – | ﹤0.01% | 1759 |
|
|
2023
Q3 | $30.9K | Hold |
3,051
| – | – | ﹤0.01% | 1665 |
|
|
2023
Q2 | $38.1K | Hold |
3,051
| – | – | ﹤0.01% | 1589 |
|
|
2023
Q1 | $35.6K | Sell |
3,051
-212
| -6% | -$2.47K | ﹤0.01% | 1575 |
|
|
2022
Q4 | $34.7K | Hold |
3,263
| – | – | ﹤0.01% | 1698 |
|
|
2022
Q3 | $31.7K | Hold |
3,263
| – | – | ﹤0.01% | 1765 |
|
|
2022
Q2 | $47.3K | Hold |
3,263
| – | – | ﹤0.01% | 1545 |
|
|
2022
Q1 | $85.3K | Sell |
3,263
-9,967
| -75% | -$260K | ﹤0.01% | 1295 |
|
|
2021
Q4 | $524K | Hold |
13,230
| – | – | 0.01% | 1387 |
|
|
2021
Q3 | $662K | Buy |
13,230
+867
| +7% | +$43.4K | 0.01% | 1260 |
|
|
2021
Q2 | $686K | Buy |
12,363
+2,616
| +27% | +$145K | 0.01% | 1304 |
|
|
2021
Q1 | $456K | Sell |
9,747
-365
| -4% | -$17.1K | 0.01% | 1483 |
|
|
2020
Q4 | $440K | Hold |
10,112
| – | – | 0.01% | 1441 |
|
|
2020
Q3 | $370K | Hold |
10,112
| – | – | 0.01% | 1410 |
|
|
2020
Q2 | $295K | Buy |
10,112
+4,007
| +66% | +$117K | 0.01% | 1554 |
|
|
2020
Q1 | $160K | Buy |
6,105
+3,347
| +121% | +$87.5K | ﹤0.01% | 1727 |
|
|
2019
Q4 | $95.7K | Sell |
2,758
-2,316
| -46% | -$80.4K | ﹤0.01% | 2362 |
|
|
2019
Q3 | $161K | Buy |
+5,074
| New | +$161K | ﹤0.01% | 2030 |
|